Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Societe D'Exploitation De Produits Pour Les Industries Chimiques Seppic has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. Prosecution is currently handled by 1 distinct examiner across 1 distinct art unit. GULLEDGE, BRIAN M is the busiest examiner, responsible for 1 busiest examiner pending office action. The company's focus on Biotechnology & Pharmaceuticals is currently channeled through a single point of contact at the patent office. Having a single examiner and a single unit suggests a narrow or early-stage portfolio.
The 1 pending office action represents the total current workload for this applicant. Practitioners can focus their efforts on the specific requirements of 1 distinct art unit, as there is no current exposure to other examination environments. Because GULLEDGE, BRIAN M is the only examiner involved, the 1 busiest examiner pending action is the primary focus of the prosecution strategy. This lack of examiner variety means the applicant can develop a deep understanding of the specific preferences of 1 distinct examiner. This matter serves as the critical path for the company's current patenting goals.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GULLEDGE, BRIAN M | 1 | 55.8% | +26.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256553 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | GULLEDGE, BRIAN M | 70d |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18256553 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | GULLEDGE, BRIAN M | 1699 | §103 | Final Rejection | 70d | Pending | Jun 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial